Pancrelipase, in general, is composed of a mixture of pancreatic enzymes which include amylases, lipases, and proteases. These enzymes are extracted from porcine pancreatic glands. The pancrelipase mixture was developed by Ortho-McNeil-Janssen Pharmaceuticals, Inc and FDA approved on April 12, 2010. For further information on the components of this mixture p...
The use of pancrelipase amylase is part of the pancreatic enzyme replacement therapy. This therapy is indicated for the treatment of pancreatic insufficiency attributed to cystic fibrosis, chronic pancreatitis or any other medically defined pancreatic disease that might require it. Pancreatic diseases are associated with the deterioration of pancreatic paren...
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Children's Hospital Colroado, Aurora, Colorado, United States
Site reference no. 112520, Málaga, Spain
Site reference no. 113475, Ulm, Germany
Site reference no. 113456, Bochum, Germany
Department of Gastroenterology, Sheffield, South Yorkshire, United Kingdom
Site Reference ID/Investigator# 80715, Orenburg, Russian Federation
Site Reference ID/Investigator# 80716, Barnaul, Russian Federation
Site Reference ID/Investigator# 80698, Novosibirsk, Russian Federation
Baton Rouge Family Practice, Baton Rouge, Louisiana, United States
American Academy of Family Physicians-National Research Network, Leawood, Kansas, United States
Torrance Clinical Research, Lomita, California, United States
Site reference ID/Investigator # 96698, Aichi, Japan
Research facility ORG-000972, Ehime, Japan
Site Reference ID/Investigator# 65530, Kagawa, Japan
Centre de Recherche sur Volontaires, Bobigny, France
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.